Central melanocortin system

Mechanism of action

The melanocortin system is a critical regulator of energy balance, in both feeding behaviors and energy expenditure, as well as peripheral tissues such as skin and hair. This system is a principal nexus of body weight regulation through its role in appetite and energy expenditure via leptin, ghrelin and agouti-related protein. It receives inputs from hormones, nutrients and afferent neural inputs, and is unique in its composition of fibers which express both agonists and antagonists of melanocortin receptors. Much of what is known about brain control's of overall energy balance and fat storage stem from the discoveries about the hypothalamic melanocortin system and leptin.

Research into appetite-suppressants have further highlighted the role of the melanocortin system in weight homeostasis. Nicotine's appetite-suppressant effect appears to result from nicotine's stimulation of α3β4 nAChR receptors located in the POMC neurons in the arcuate nucleus and subsequently the melanocortin system via the melanocortin-4 receptors on second-order neurons in the paraventricular nucleus of the hypothalamus. Serotonin plays an essential role in mediating energy balance, including appetite suppression and weight reduction, by stimulation of the melanocortin-4 receptors,

• as was previously hypothesized, by a pathway to the brain stem via the hypothalamus, even though there are also peripheral pathways. Circadian rhythm signals also affect the melanocortin system, both directly with melatonin affecting POMC gene expression in the arcuate nucleas, and indirectly via the interdependence between serotonin and melatonin cycles. Selenoproteins indirectly regulate the melatocortin system via redox homeostasis.

Therapeutic implications

Due to the essential role of melanocortins in the regulation of body weight and appetite, they are a target of choice for anti-obesity drugs development, such as setmelanotide and lorcaserin, but also diabetes, cachexia and eating disorders such as anorexia. Other drugs target the serotonergic system to indirectly affect the melanocortin system for the treatment of obesity. However, it is important to note that this system also elicits effects on cardiovascular and sexual function.

Stimulation of the melanocortin-4 receptor causes a decrease in appetite and an increase in metabolism of fat and lean body mass, even in a relatively starved state. Conversely, damage to this receptor has been shown to result in morbid obesity, and is the most commonly known cause of monogenic morbid obesity. Mutation in an allele of the melanocortin-4 receptor causes 2-3% of childhood and adult obesity. Deficiencies and mutations in the melanocortin-4 receptors were also identified in the general population, thus rendering obsolete the distinction between rare monogenic obesity and common polygenic obesity.

References

Additional bibliography

• Cone (2005) Anatomy and Regulation of the Central Melanocortin System Nature Neuroscience 7: 1048-54
• Daniel L. Marks, Nicholas Ling and Roger D. Cone (2001) Role of the Central Melanocortin System in Cachexia Cancer Research 61, 1432- 1438
• Joyce J. Hwa, Lorraine Ghibaudi, Jun Gao, and Eric M. Parker (2001) Central melanocortin system modulates energy intake and expenditure of obese and lean Zucker rats AJP-Regulatory, Integrative and Comparative Physiology Vol. 281, Issue 2, R444-R451

References

1. (July 2009). "Role of central melanocortin pathways in energy homeostasis.". Trends in Endocrinology and Metabolism.
2. (December 2018). "Pharmacological Effects and Regulatory Mechanisms of Tobacco Smoking Effects on Food Intake and Weight Control". Journal of Neuroimmune Pharmacology.
3. (October 2012). "Unraveling the brain regulation of appetite: lessons from genetics.". Nature Neuroscience.
4. (June 2004). "Brain circuits regulating energy homeostasis.". The Neuroscientist.
5. (2016). "The Role of PVH Circuits in Leptin Action and Energy Balance.". Annual Review of Physiology.
6. (January 2014). "Molecules and circuits involved in nicotine addiction: The many faces of smoking.". Neuropharmacology.
7. (November 2007). "Serotonin and the orchestration of energy balance.". Cell Metabolism.
8. (November 2010). "Brain serotonin system in the coordination of food intake and body weight.". Pharmacology, Biochemistry, and Behavior.
9. (October 2005). "Serotonergic pathways converge upon central melanocortin systems to regulate energy balance.". Peptides.
10. (2013). "Serotonin and the regulation of mammalian energy balance.". Frontiers in Neuroscience.
11. (1 November 2012). "A review on the effect of the photoperiod and melatonin on interactions between ghrelin and serotonin.". General and Comparative Endocrinology.
12. (1 November 2018). "Hypothalamic redox balance and leptin signaling - Emerging role of selenoproteins.". Free Radical Biology & Medicine.
13. (16 August 2002). "The role of melanocortins in body weight regulation: opportunities for the treatment of obesity.". European Journal of Pharmacology.
14. (December 2009). "New central targets for the treatment of obesity.". British Journal of Clinical Pharmacology.
15. (March 2018). "Safety and tolerability of new-generation anti-obesity medications: a narrative review.". Postgraduate Medicine.
16. (October 2016). "Safety and tolerability review of lorcaserin in clinical trials.". Clinical Obesity.
17. (June 2015). "5-hydroxytryptamine medications for the treatment of obesity.". Journal of Neuroendocrinology.
18. (December 2010). "Contribution of anorexia to tissue wasting in cachexia.". Current Opinion in Supportive and Palliative Care.
19. (2011). "Serotonergic Anti-Obesity Agents". Drugs.
20. (15 February 2001). "Role of the central melanocortin system in cachexia.". Cancer Research.
21. (September 2003). "Minireview: human obesity-lessons from monogenic disorders.". Endocrinology.
22. (2016). "Rare Genetic Forms of Obesity: Clinical Approach and Current Treatments in 2016.". Obesity Facts.
23. (March 1999). "The central melanocortin system and its role in energy homeostasis". Annales d'endocrinologie.
24. (18 August 2018). "Genetics of Severe Obesity.". Current Diabetes Reports.